First Trust Nasdaq Pharmaceuticals ETF (FTXH) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free FTXH Stock Alerts $26.80 -0.09 (-0.33%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadline3 Health Care ETFs You'll Want to Own When the Market Recoversstocknews.com - August 3 at 4:00 PMSurprising Analyst 12-Month Target For FTXHnasdaq.com - May 25 at 11:30 AMFirst Trust Nasdaq Pharmaceuticals ETF declares quarterly distribution of $0.0488seekingalpha.com - March 25 at 5:58 PMSolid Q4 Earnings Fail to Impress Pharma ETFsnasdaq.com - February 22 at 4:36 PMWave of Solid Q3 Earnings Push Pharma ETFs Highernasdaq.com - November 9 at 12:00 PM4 ETF Strategies to Follow Warren Buffett's Visionmsn.com - August 19 at 11:47 AM Get First Trust Nasdaq Pharmaceuticals ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for FTXH and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk Secret Crypto Plot Exposed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. FTXH Media Mentions By Week FTXH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FTXH News Sentiment▼1.461.08▲Average Manufacturing News Sentiment FTXH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FTXH Articles This Week▼10▲FTXH Articles Average Week Get First Trust Nasdaq Pharmaceuticals ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for FTXH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IBBQ News BTEC News BIB News PSCH News BBH News PPH News IBB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FTXH) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
